COMPLETE KIT INCLUDEDbacteriostatic water, syringes, protocol and guide with every order

Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•
BioPeptideX logoBioPeptideX
Back

Research guide · Cellular Energy

PNC-27 — research protocol

Synthetic membrane-targeting peptide investigated in oncology and cellular studies.

Evidence boundary

This guide summarizes study areas and sources associated with the compound. BioPeptideX does not convert experimental information into a clinical regimen or recommend an individual dose, frequency, route or duration.

Catalog presentations

5mg10mg15mg

Concentration table

Mathematical reference only; this is not a dosing recommendation.

Resulting concentration2.50 mg/mL
On a U-100 syringe · 1 unit contains0.025 mg

Research areas

  • Membrane-targeting peptide
  • Compound
  • Lyophilized form

Limited protocol information

We do not publish a cycle or dose range for this compound because the catalog references are not sufficient to support a responsible regimen. Consult the original publications and a licensed professional.

Handling and storage

Store unreconstituted product according to its label and maintain the cold chain where applicable. After any preparation, follow only validated instructions for the specific product and diluent. Do not use if packaging is damaged or the solution shows particles or unexpected changes.

Warnings

Do not use this page for self-diagnosis or self-medication. Pregnancy, breastfeeding, minors, cancer history, allergies, active disease and concurrent treatments require individual professional evaluation.

Published sources

  1. 1.Sarafraz-Yazdi E, et al. PNAS, 2010.
  2. 2.Bowne WB, et al. Surgery, 2008.